 Paco Herson
Concepts (495)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain Ischemia | 37 | 2026 | 358 | 9.650 |
Why?
| | TRPM Cation Channels | 12 | 2024 | 75 | 5.130 |
Why?
| | Heart Arrest | 26 | 2026 | 407 | 5.050 |
Why?
| | Hippocampus | 24 | 2026 | 965 | 3.210 |
Why?
| | Stroke | 22 | 2025 | 1254 | 3.140 |
Why?
| | Neuroprotective Agents | 16 | 2020 | 143 | 2.890 |
Why?
| | Neurons | 31 | 2023 | 1640 | 2.870 |
Why?
| | Cardiopulmonary Resuscitation | 16 | 2025 | 340 | 2.510 |
Why?
| | Sex Characteristics | 16 | 2024 | 789 | 2.170 |
Why?
| | Cell Death | 16 | 2021 | 383 | 1.980 |
Why?
| | Purkinje Cells | 7 | 2019 | 64 | 1.950 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 7 | 2024 | 195 | 1.700 |
Why?
| | Recovery of Function | 6 | 2025 | 706 | 1.660 |
Why?
| | CA1 Region, Hippocampal | 7 | 2024 | 51 | 1.520 |
Why?
| | Mice, Inbred C57BL | 48 | 2025 | 5988 | 1.510 |
Why?
| | Gonadal Steroid Hormones | 5 | 2025 | 144 | 1.320 |
Why?
| | Animals | 98 | 2026 | 38030 | 1.310 |
Why?
| | Androgens | 8 | 2014 | 186 | 1.290 |
Why?
| | Mice | 65 | 2026 | 18329 | 1.280 |
Why?
| | Long-Term Potentiation | 9 | 2026 | 200 | 1.220 |
Why?
| | Ischemia | 5 | 2022 | 421 | 1.130 |
Why?
| | Neuroprotection | 3 | 2020 | 46 | 1.090 |
Why?
| | Receptors, GABA-A | 5 | 2024 | 138 | 1.080 |
Why?
| | Disease Models, Animal | 25 | 2026 | 4556 | 1.070 |
Why?
| | Peptide Fragments | 2 | 2021 | 698 | 0.990 |
Why?
| | Signal Transduction | 11 | 2024 | 5221 | 0.940 |
Why?
| | Infarction, Middle Cerebral Artery | 12 | 2023 | 41 | 0.920 |
Why?
| | Poly(ADP-ribose) Polymerases | 4 | 2013 | 86 | 0.880 |
Why?
| | Hypothermia, Induced | 3 | 2016 | 96 | 0.840 |
Why?
| | Reperfusion Injury | 8 | 2020 | 300 | 0.840 |
Why?
| | Neuronal Plasticity | 9 | 2026 | 309 | 0.820 |
Why?
| | Small-Conductance Calcium-Activated Potassium Channels | 5 | 2014 | 13 | 0.810 |
Why?
| | Calcium | 10 | 2022 | 1182 | 0.780 |
Why?
| | Male | 72 | 2026 | 72035 | 0.780 |
Why?
| | Cognition | 4 | 2026 | 1258 | 0.760 |
Why?
| | Brain Injuries | 5 | 2021 | 506 | 0.710 |
Why?
| | Brain Injuries, Traumatic | 4 | 2023 | 441 | 0.710 |
Why?
| | Brain | 13 | 2024 | 2930 | 0.700 |
Why?
| | Thrombosis | 3 | 2022 | 393 | 0.690 |
Why?
| | Patch-Clamp Techniques | 13 | 2019 | 289 | 0.680 |
Why?
| | Excitatory Postsynaptic Potentials | 3 | 2016 | 117 | 0.650 |
Why?
| | Brain-Derived Neurotrophic Factor | 5 | 2026 | 148 | 0.650 |
Why?
| | Sex Factors | 11 | 2024 | 2096 | 0.650 |
Why?
| | Receptors, N-Methyl-D-Aspartate | 4 | 2020 | 226 | 0.630 |
Why?
| | Cerebellum | 4 | 2011 | 223 | 0.620 |
Why?
| | Pregnanolone | 2 | 2011 | 35 | 0.610 |
Why?
| | Potassium Channels | 8 | 2003 | 145 | 0.600 |
Why?
| | Nogo Proteins | 1 | 2019 | 10 | 0.590 |
Why?
| | Estradiol | 5 | 2018 | 533 | 0.590 |
Why?
| | Neural Inhibition | 3 | 2024 | 178 | 0.550 |
Why?
| | Nerve Regeneration | 1 | 2018 | 56 | 0.540 |
Why?
| | Adult Stem Cells | 1 | 2018 | 39 | 0.540 |
Why?
| | Long-Term Synaptic Depression | 2 | 2018 | 51 | 0.520 |
Why?
| | Guideline Adherence | 1 | 2022 | 586 | 0.510 |
Why?
| | Estrogens | 5 | 2013 | 380 | 0.500 |
Why?
| | Nervous System Diseases | 1 | 2019 | 282 | 0.490 |
Why?
| | Cognitive Dysfunction | 2 | 2019 | 451 | 0.490 |
Why?
| | Neurogenesis | 1 | 2018 | 156 | 0.480 |
Why?
| | Clotrimazole | 2 | 2013 | 3 | 0.480 |
Why?
| | Cerebrovascular Disorders | 2 | 2024 | 103 | 0.480 |
Why?
| | Neural Stem Cells | 1 | 2018 | 166 | 0.480 |
Why?
| | Mice, Knockout | 11 | 2021 | 3119 | 0.470 |
Why?
| | Female | 44 | 2025 | 77976 | 0.460 |
Why?
| | Aging | 3 | 2019 | 1964 | 0.460 |
Why?
| | Sirtuin 2 | 1 | 2015 | 27 | 0.460 |
Why?
| | Microglia | 5 | 2018 | 268 | 0.450 |
Why?
| | Membrane Glycoproteins | 1 | 2018 | 496 | 0.450 |
Why?
| | Protein-Tyrosine Kinases | 1 | 2018 | 433 | 0.430 |
Why?
| | Emergency Medical Services | 1 | 2022 | 696 | 0.430 |
Why?
| | Cell Hypoxia | 4 | 2013 | 247 | 0.420 |
Why?
| | Cell Culture Techniques | 3 | 2013 | 375 | 0.420 |
Why?
| | Tissue Plasminogen Activator | 3 | 2022 | 244 | 0.420 |
Why?
| | Oxygen | 4 | 2012 | 995 | 0.420 |
Why?
| | Animal Experimentation | 1 | 2014 | 8 | 0.420 |
Why?
| | Kynurenine | 2 | 2025 | 113 | 0.410 |
Why?
| | Models, Animal | 2 | 2013 | 392 | 0.400 |
Why?
| | Inhibitory Postsynaptic Potentials | 2 | 2011 | 48 | 0.400 |
Why?
| | Naltrexone | 1 | 2015 | 117 | 0.400 |
Why?
| | Rats | 18 | 2023 | 5592 | 0.390 |
Why?
| | Cerebral Cortex | 3 | 2021 | 464 | 0.380 |
Why?
| | Potassium Channels, Voltage-Gated | 2 | 2003 | 55 | 0.380 |
Why?
| | Ion Channels | 4 | 2004 | 129 | 0.360 |
Why?
| | Peptides | 3 | 2023 | 995 | 0.360 |
Why?
| | Memory | 4 | 2026 | 294 | 0.350 |
Why?
| | Magnetic Fields | 3 | 2022 | 24 | 0.340 |
Why?
| | Receptors, AMPA | 3 | 2026 | 147 | 0.340 |
Why?
| | Synapses | 4 | 2021 | 439 | 0.320 |
Why?
| | Hydrogen Peroxide | 4 | 2020 | 336 | 0.320 |
Why?
| | Oxidative Stress | 7 | 2020 | 1339 | 0.310 |
Why?
| | Action Potentials | 7 | 2022 | 506 | 0.310 |
Why?
| | Adrenergic alpha-2 Receptor Agonists | 3 | 2014 | 25 | 0.310 |
Why?
| | Progesterone | 3 | 2010 | 255 | 0.300 |
Why?
| | Dexmedetomidine | 3 | 2014 | 44 | 0.300 |
Why?
| | Age Factors | 5 | 2021 | 3313 | 0.290 |
Why?
| | Immunohistochemistry | 7 | 2016 | 1715 | 0.290 |
Why?
| | Cells, Cultured | 10 | 2018 | 4146 | 0.280 |
Why?
| | Calcium Channels, T-Type | 2 | 2022 | 105 | 0.280 |
Why?
| | Rats, Sprague-Dawley | 9 | 2023 | 2525 | 0.280 |
Why?
| | Ion Channel Gating | 6 | 2004 | 92 | 0.280 |
Why?
| | Drug Delivery Systems | 2 | 2022 | 379 | 0.280 |
Why?
| | Glucose | 7 | 2014 | 1046 | 0.280 |
Why?
| | NAD | 2 | 1999 | 81 | 0.270 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2014 | 1128 | 0.270 |
Why?
| | Sepsis | 3 | 2019 | 640 | 0.270 |
Why?
| | HEK293 Cells | 3 | 2020 | 744 | 0.260 |
Why?
| | Memory Disorders | 2 | 2019 | 193 | 0.260 |
Why?
| | Humans | 36 | 2025 | 144261 | 0.250 |
Why?
| | Brain Infarction | 3 | 2016 | 23 | 0.250 |
Why?
| | Tryptophan | 2 | 2025 | 180 | 0.250 |
Why?
| | Time Factors | 12 | 2025 | 7155 | 0.250 |
Why?
| | Colloids | 2 | 2017 | 61 | 0.240 |
Why?
| | Dose-Response Relationship, Drug | 5 | 2019 | 2026 | 0.240 |
Why?
| | Dihydrotestosterone | 5 | 2013 | 42 | 0.230 |
Why?
| | Protective Agents | 2 | 2019 | 42 | 0.230 |
Why?
| | Paraplegia | 2 | 2015 | 61 | 0.210 |
Why?
| | Olfactory Receptor Neurons | 1 | 2004 | 42 | 0.200 |
Why?
| | GABAergic Neurons | 1 | 2024 | 35 | 0.200 |
Why?
| | Myelin Proteins | 3 | 2016 | 45 | 0.200 |
Why?
| | Oxidants | 2 | 2020 | 103 | 0.200 |
Why?
| | Military Personnel | 2 | 2023 | 709 | 0.200 |
Why?
| | Receptors, Adrenergic, alpha-2 | 2 | 2013 | 11 | 0.200 |
Why?
| | Epoxide Hydrolases | 2 | 2013 | 13 | 0.200 |
Why?
| | Glycosaminoglycans | 1 | 2023 | 74 | 0.200 |
Why?
| | Calmodulin | 2 | 2019 | 70 | 0.200 |
Why?
| | Spinocerebellar Degenerations | 1 | 2003 | 7 | 0.200 |
Why?
| | Potassium Channels, Calcium-Activated | 4 | 2004 | 11 | 0.200 |
Why?
| | Smell | 1 | 2004 | 128 | 0.200 |
Why?
| | Aspartic Acid Endopeptidases | 1 | 2023 | 32 | 0.190 |
Why?
| | Orchiectomy | 3 | 2013 | 74 | 0.190 |
Why?
| | Poly (ADP-Ribose) Polymerase-1 | 2 | 2013 | 53 | 0.190 |
Why?
| | Amyloid beta-Protein Precursor | 1 | 2023 | 64 | 0.190 |
Why?
| | Corpus Striatum | 4 | 2016 | 179 | 0.190 |
Why?
| | Spinal Cord Ischemia | 2 | 2013 | 60 | 0.190 |
Why?
| | Pneumonia | 2 | 2021 | 630 | 0.190 |
Why?
| | Behavior, Animal | 3 | 2018 | 519 | 0.190 |
Why?
| | Blood-Brain Barrier | 2 | 2022 | 155 | 0.190 |
Why?
| | Spinal Cord | 3 | 2014 | 380 | 0.190 |
Why?
| | Amyloid Precursor Protein Secretases | 1 | 2023 | 77 | 0.190 |
Why?
| | Primary Cell Culture | 2 | 2013 | 173 | 0.180 |
Why?
| | Cerebral Infarction | 1 | 2022 | 47 | 0.180 |
Why?
| | Cerebrovascular Circulation | 1 | 2024 | 278 | 0.180 |
Why?
| | Emergency Medical Dispatch | 1 | 2022 | 6 | 0.180 |
Why?
| | Myelin Sheath | 3 | 2023 | 168 | 0.180 |
Why?
| | Phosphorylation | 4 | 2023 | 1732 | 0.180 |
Why?
| | Information Systems | 1 | 2022 | 57 | 0.180 |
Why?
| | Plasminogen | 1 | 2021 | 27 | 0.180 |
Why?
| | Metabolomics | 2 | 2024 | 726 | 0.180 |
Why?
| | Receptors, Androgen | 3 | 2013 | 153 | 0.180 |
Why?
| | Benzimidazoles | 2 | 2014 | 190 | 0.170 |
Why?
| | Heroin | 1 | 2021 | 29 | 0.170 |
Why?
| | Organ Culture Techniques | 1 | 2021 | 154 | 0.170 |
Why?
| | Blotting, Western | 5 | 2012 | 1187 | 0.170 |
Why?
| | Single-Cell Analysis | 1 | 2024 | 356 | 0.170 |
Why?
| | Cell Survival | 6 | 2020 | 1098 | 0.170 |
Why?
| | Spinal Cord Injuries | 2 | 2015 | 240 | 0.170 |
Why?
| | Encephalitis | 2 | 2014 | 139 | 0.170 |
Why?
| | Presynaptic Terminals | 1 | 2021 | 86 | 0.170 |
Why?
| | Eclampsia | 1 | 2020 | 6 | 0.170 |
Why?
| | Islets of Langerhans | 2 | 1997 | 832 | 0.170 |
Why?
| | Insulinoma | 2 | 1997 | 27 | 0.160 |
Why?
| | Metabolome | 1 | 2024 | 384 | 0.160 |
Why?
| | gamma-Aminobutyric Acid | 2 | 2017 | 192 | 0.160 |
Why?
| | Cell-Derived Microparticles | 1 | 2021 | 75 | 0.160 |
Why?
| | Amyloid beta-Peptides | 1 | 2023 | 240 | 0.160 |
Why?
| | Extinction, Psychological | 1 | 2021 | 92 | 0.160 |
Why?
| | Adaptation, Physiological | 1 | 2004 | 569 | 0.160 |
Why?
| | Thalamus | 1 | 2021 | 125 | 0.160 |
Why?
| | Death-Associated Protein Kinases | 1 | 2020 | 10 | 0.160 |
Why?
| | tat Gene Products, Human Immunodeficiency Virus | 1 | 2019 | 25 | 0.150 |
Why?
| | rho GTP-Binding Proteins | 1 | 2020 | 56 | 0.150 |
Why?
| | Cell Membrane | 2 | 2003 | 706 | 0.150 |
Why?
| | Fibrinolysis | 2 | 2021 | 162 | 0.150 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 4 | 2010 | 981 | 0.150 |
Why?
| | Inhibitory Concentration 50 | 1 | 2019 | 91 | 0.150 |
Why?
| | Mesenchymal Stem Cell Transplantation | 1 | 2020 | 59 | 0.150 |
Why?
| | Intravital Microscopy | 1 | 2019 | 25 | 0.150 |
Why?
| | Optical Imaging | 1 | 2019 | 64 | 0.150 |
Why?
| | Insulin | 3 | 1999 | 2501 | 0.150 |
Why?
| | Models, Theoretical | 1 | 2023 | 582 | 0.150 |
Why?
| | Glycogen Synthase Kinase 3 beta | 1 | 2019 | 72 | 0.150 |
Why?
| | Axons | 2 | 2018 | 201 | 0.150 |
Why?
| | Fibrinolytic Agents | 1 | 2022 | 291 | 0.150 |
Why?
| | Cofilin 1 | 1 | 2018 | 5 | 0.140 |
Why?
| | Mice, Transgenic | 6 | 2016 | 2182 | 0.140 |
Why?
| | Oligosaccharides | 1 | 2019 | 60 | 0.140 |
Why?
| | Extracellular Vesicles | 1 | 2021 | 170 | 0.140 |
Why?
| | Mutagenesis | 1 | 2019 | 190 | 0.140 |
Why?
| | Calcineurin | 1 | 2019 | 105 | 0.140 |
Why?
| | Drug Design | 1 | 2019 | 173 | 0.140 |
Why?
| | Protein Aggregation, Pathological | 1 | 2018 | 22 | 0.140 |
Why?
| | Structure-Activity Relationship | 1 | 2019 | 567 | 0.140 |
Why?
| | Nerve Net | 1 | 2021 | 285 | 0.140 |
Why?
| | Thalamic Nuclei | 1 | 2018 | 9 | 0.140 |
Why?
| | Holoenzymes | 1 | 2018 | 25 | 0.140 |
Why?
| | Pre-Eclampsia | 1 | 2020 | 204 | 0.140 |
Why?
| | Biomedical Research | 1 | 2024 | 709 | 0.140 |
Why?
| | Interleukin-10 | 3 | 2015 | 309 | 0.140 |
Why?
| | Receptor, trkB | 1 | 2018 | 36 | 0.140 |
Why?
| | Lateral Ventricles | 1 | 2018 | 32 | 0.130 |
Why?
| | Myelin Proteolipid Protein | 1 | 2018 | 60 | 0.130 |
Why?
| | Molecular Dynamics Simulation | 1 | 2019 | 258 | 0.130 |
Why?
| | Heparin | 1 | 2019 | 243 | 0.130 |
Why?
| | Intracranial Arterial Diseases | 1 | 2017 | 8 | 0.130 |
Why?
| | Alloxan | 1 | 1997 | 4 | 0.130 |
Why?
| | Membrane Proteins | 2 | 2021 | 1165 | 0.130 |
Why?
| | Receptors, Glutamate | 1 | 2016 | 26 | 0.130 |
Why?
| | Cerebral Arteries | 1 | 2017 | 58 | 0.130 |
Why?
| | Mitochondria | 2 | 2021 | 983 | 0.130 |
Why?
| | Glutathione | 1 | 1999 | 375 | 0.130 |
Why?
| | Gene Knockdown Techniques | 2 | 2020 | 336 | 0.120 |
Why?
| | Dementia | 1 | 2020 | 302 | 0.120 |
Why?
| | Leukoencephalopathies | 1 | 2016 | 24 | 0.120 |
Why?
| | Actins | 1 | 2018 | 422 | 0.120 |
Why?
| | Pericytes | 1 | 2016 | 36 | 0.120 |
Why?
| | Cations | 3 | 2003 | 82 | 0.120 |
Why?
| | Spleen | 3 | 2015 | 508 | 0.120 |
Why?
| | Furans | 1 | 2015 | 27 | 0.120 |
Why?
| | Inflammation | 4 | 2021 | 2877 | 0.120 |
Why?
| | Collagen Type I | 1 | 2016 | 147 | 0.110 |
Why?
| | Cell Communication | 2 | 2016 | 324 | 0.110 |
Why?
| | Tretinoin | 1 | 2016 | 124 | 0.110 |
Why?
| | Real-Time Polymerase Chain Reaction | 2 | 2013 | 341 | 0.110 |
Why?
| | Transfection | 2 | 2016 | 938 | 0.110 |
Why?
| | Arginase | 1 | 2015 | 27 | 0.110 |
Why?
| | Magnetic Resonance Angiography | 1 | 2017 | 251 | 0.110 |
Why?
| | Interleukin-1beta | 2 | 2014 | 395 | 0.110 |
Why?
| | Membrane Potentials | 5 | 1999 | 280 | 0.110 |
Why?
| | Calbindins | 1 | 2014 | 6 | 0.110 |
Why?
| | Cardiovascular Surgical Procedures | 1 | 2014 | 30 | 0.110 |
Why?
| | Neutrophil Activation | 1 | 2015 | 85 | 0.110 |
Why?
| | Dizocilpine Maleate | 1 | 2014 | 24 | 0.110 |
Why?
| | Brain Concussion | 1 | 2023 | 638 | 0.110 |
Why?
| | Calcium Channel Agonists | 1 | 2014 | 12 | 0.110 |
Why?
| | Trauma, Nervous System | 1 | 2014 | 3 | 0.110 |
Why?
| | Toll-Like Receptor 4 | 2 | 2013 | 276 | 0.110 |
Why?
| | Tissue Culture Techniques | 1 | 2014 | 83 | 0.110 |
Why?
| | Excitatory Amino Acid Antagonists | 1 | 2014 | 107 | 0.110 |
Why?
| | Microinjections | 2 | 2011 | 92 | 0.110 |
Why?
| | Nerve Tissue Proteins | 2 | 2016 | 592 | 0.110 |
Why?
| | Mutation | 2 | 2020 | 4085 | 0.110 |
Why?
| | Lentivirus | 2 | 2011 | 60 | 0.100 |
Why?
| | Quinolines | 1 | 2015 | 190 | 0.100 |
Why?
| | Analysis of Variance | 3 | 2015 | 1304 | 0.100 |
Why?
| | Aged | 6 | 2025 | 25850 | 0.100 |
Why?
| | Aortic Diseases | 1 | 2015 | 124 | 0.100 |
Why?
| | CD40 Antigens | 1 | 2014 | 90 | 0.100 |
Why?
| | Practice Guidelines as Topic | 1 | 2022 | 1559 | 0.100 |
Why?
| | Cross Infection | 1 | 2016 | 262 | 0.100 |
Why?
| | Arachidonic Acids | 1 | 2013 | 43 | 0.100 |
Why?
| | Electroencephalography | 1 | 2016 | 532 | 0.100 |
Why?
| | Body Temperature | 1 | 2014 | 228 | 0.100 |
Why?
| | Immunophenotyping | 1 | 2014 | 322 | 0.100 |
Why?
| | bcl-2-Associated X Protein | 1 | 2013 | 54 | 0.100 |
Why?
| | Embryo, Mammalian | 1 | 2013 | 232 | 0.100 |
Why?
| | Piperidines | 1 | 2014 | 217 | 0.100 |
Why?
| | Immune Tolerance | 1 | 2015 | 379 | 0.090 |
Why?
| | Glomerular Filtration Barrier | 1 | 2012 | 1 | 0.090 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2013 | 204 | 0.090 |
Why?
| | Ovariectomy | 3 | 2025 | 162 | 0.090 |
Why?
| | Polymerase Chain Reaction | 3 | 2012 | 1054 | 0.090 |
Why?
| | Testosterone | 3 | 2010 | 419 | 0.090 |
Why?
| | RNA, Small Interfering | 2 | 2011 | 634 | 0.090 |
Why?
| | Endothelium | 1 | 2012 | 119 | 0.090 |
Why?
| | Microscopy, Immunoelectron | 1 | 2011 | 43 | 0.090 |
Why?
| | Encephalomyelitis, Autoimmune, Experimental | 1 | 2011 | 66 | 0.080 |
Why?
| | Up-Regulation | 2 | 2025 | 851 | 0.080 |
Why?
| | Culture Media | 1 | 2011 | 160 | 0.080 |
Why?
| | Iraq War, 2003-2011 | 2 | 2023 | 164 | 0.080 |
Why?
| | Acute Lung Injury | 1 | 2014 | 302 | 0.080 |
Why?
| | Pyramidal Cells | 1 | 2011 | 79 | 0.080 |
Why?
| | Afghan Campaign 2001- | 2 | 2023 | 184 | 0.080 |
Why?
| | Treatment Outcome | 3 | 2022 | 11643 | 0.080 |
Why?
| | Biomarkers | 2 | 2025 | 4254 | 0.080 |
Why?
| | Child | 4 | 2019 | 22537 | 0.080 |
Why?
| | Isoflurane | 1 | 2010 | 41 | 0.080 |
Why?
| | United States | 3 | 2023 | 15876 | 0.080 |
Why?
| | Cell Line | 5 | 2012 | 2879 | 0.080 |
Why?
| | Retrospective Studies | 7 | 2023 | 17009 | 0.080 |
Why?
| | Anesthetics, Inhalation | 1 | 2010 | 52 | 0.080 |
Why?
| | Genetic Vectors | 1 | 2011 | 337 | 0.080 |
Why?
| | Cell Movement | 1 | 2014 | 965 | 0.080 |
Why?
| | In Vitro Techniques | 1 | 2011 | 1047 | 0.080 |
Why?
| | Motor Activity | 2 | 2011 | 720 | 0.080 |
Why?
| | Ischemic Attack, Transient | 1 | 2010 | 71 | 0.070 |
Why?
| | Disease Progression | 1 | 2017 | 2840 | 0.070 |
Why?
| | Recombinant Fusion Proteins | 2 | 2011 | 674 | 0.070 |
Why?
| | Aged, 80 and over | 4 | 2025 | 8243 | 0.070 |
Why?
| | RNA, Messenger | 4 | 2018 | 2829 | 0.070 |
Why?
| | Neutrophils | 1 | 2015 | 1134 | 0.070 |
Why?
| | Pregnancy | 3 | 2020 | 7180 | 0.070 |
Why?
| | Oligodendroglia | 2 | 2023 | 187 | 0.070 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2013 | 905 | 0.070 |
Why?
| | Apoptosis | 3 | 2016 | 2430 | 0.070 |
Why?
| | Animals, Newborn | 2 | 2023 | 901 | 0.060 |
Why?
| | Risk Assessment | 3 | 2025 | 3637 | 0.060 |
Why?
| | Receptors, Antigen, T-Cell | 1 | 2011 | 668 | 0.060 |
Why?
| | Kidney | 2 | 2012 | 1495 | 0.060 |
Why?
| | In Situ Nick-End Labeling | 1 | 2006 | 121 | 0.060 |
Why?
| | Menopause | 1 | 2010 | 319 | 0.060 |
Why?
| | Acute Kidney Injury | 1 | 2014 | 862 | 0.060 |
Why?
| | Muscle Denervation | 2 | 2002 | 8 | 0.060 |
Why?
| | Hypoxia-Ischemia, Brain | 1 | 2006 | 46 | 0.060 |
Why?
| | Kidney Diseases | 1 | 2010 | 425 | 0.060 |
Why?
| | Tumor Cells, Cultured | 2 | 1997 | 919 | 0.060 |
Why?
| | B-Lymphocytes | 1 | 2011 | 876 | 0.060 |
Why?
| | Cyclic Nucleotide-Gated Cation Channels | 1 | 2004 | 15 | 0.050 |
Why?
| | Electrophysiology | 3 | 2003 | 218 | 0.050 |
Why?
| | Decorin | 1 | 2023 | 7 | 0.050 |
Why?
| | Hospital Mortality | 2 | 2021 | 1027 | 0.050 |
Why?
| | Infarction | 1 | 2023 | 9 | 0.050 |
Why?
| | Chondroitin Sulfates | 1 | 2023 | 35 | 0.050 |
Why?
| | Cyclic AMP | 1 | 2004 | 208 | 0.050 |
Why?
| | Kv1.1 Potassium Channel | 1 | 2003 | 8 | 0.050 |
Why?
| | Middle Aged | 5 | 2025 | 35762 | 0.050 |
Why?
| | Carbonic Anhydrases | 1 | 2003 | 12 | 0.050 |
Why?
| | Genes, Lethal | 1 | 2003 | 30 | 0.050 |
Why?
| | Shal Potassium Channels | 1 | 2003 | 5 | 0.050 |
Why?
| | Acetazolamide | 1 | 2003 | 26 | 0.050 |
Why?
| | Fasciculation | 1 | 2002 | 2 | 0.050 |
Why?
| | Iraq | 1 | 2023 | 65 | 0.050 |
Why?
| | Rats, Wistar | 2 | 2017 | 451 | 0.050 |
Why?
| | Spatial Memory | 1 | 2022 | 28 | 0.050 |
Why?
| | Afghanistan | 1 | 2023 | 95 | 0.050 |
Why?
| | Databases, Factual | 2 | 2021 | 1484 | 0.050 |
Why?
| | Extracellular Matrix Proteins | 1 | 2023 | 157 | 0.050 |
Why?
| | Risk Factors | 3 | 2025 | 10699 | 0.050 |
Why?
| | Sequence Analysis, RNA | 1 | 2024 | 442 | 0.050 |
Why?
| | Models, Neurological | 1 | 2004 | 254 | 0.050 |
Why?
| | Muscular Diseases | 1 | 2002 | 108 | 0.050 |
Why?
| | Tolbutamide | 2 | 1999 | 5 | 0.050 |
Why?
| | Fibrin Clot Lysis Time | 1 | 2021 | 10 | 0.050 |
Why?
| | Proto-Oncogene Proteins c-akt | 2 | 2014 | 436 | 0.040 |
Why?
| | Muscle, Skeletal | 2 | 2002 | 1792 | 0.040 |
Why?
| | Myelin-Oligodendrocyte Glycoprotein | 2 | 2011 | 53 | 0.040 |
Why?
| | Self Administration | 1 | 2021 | 124 | 0.040 |
Why?
| | Hypnotics and Sedatives | 1 | 2023 | 214 | 0.040 |
Why?
| | Adoptive Transfer | 2 | 2011 | 198 | 0.040 |
Why?
| | Synaptic Transmission | 1 | 2003 | 290 | 0.040 |
Why?
| | Aorta, Thoracic | 2 | 2013 | 286 | 0.040 |
Why?
| | Tumor Necrosis Factors | 1 | 2020 | 10 | 0.040 |
Why?
| | Inflammation Mediators | 2 | 2013 | 508 | 0.040 |
Why?
| | Swine | 1 | 2023 | 831 | 0.040 |
Why?
| | Nucleus Accumbens | 1 | 2021 | 132 | 0.040 |
Why?
| | Neurotoxins | 1 | 2020 | 28 | 0.040 |
Why?
| | Muscle Fibers, Skeletal | 1 | 2001 | 214 | 0.040 |
Why?
| | Stress, Physiological | 1 | 2003 | 453 | 0.040 |
Why?
| | Coculture Techniques | 1 | 2020 | 246 | 0.040 |
Why?
| | Air Ambulances | 1 | 2020 | 58 | 0.040 |
Why?
| | Thapsigargin | 1 | 1999 | 20 | 0.040 |
Why?
| | Dendritic Spines | 1 | 2020 | 69 | 0.040 |
Why?
| | Cesium | 1 | 1999 | 20 | 0.040 |
Why?
| | Ion Transport | 1 | 1999 | 63 | 0.040 |
Why?
| | Lymph Nodes | 2 | 2011 | 502 | 0.030 |
Why?
| | Promoter Regions, Genetic | 1 | 2003 | 1255 | 0.030 |
Why?
| | Recurrence | 1 | 2021 | 1134 | 0.030 |
Why?
| | Barium | 1 | 1997 | 27 | 0.030 |
Why?
| | Glutamic Acid | 1 | 2020 | 251 | 0.030 |
Why?
| | Oligodendrocyte Precursor Cells | 1 | 2018 | 23 | 0.030 |
Why?
| | Calcium Signaling | 1 | 2019 | 251 | 0.030 |
Why?
| | Thiourea | 1 | 1997 | 41 | 0.030 |
Why?
| | Magnesium | 1 | 1997 | 155 | 0.030 |
Why?
| | Free Radical Scavengers | 1 | 1997 | 81 | 0.030 |
Why?
| | Kinetics | 2 | 1997 | 1627 | 0.030 |
Why?
| | Oligopeptides | 1 | 1999 | 268 | 0.030 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2018 | 269 | 0.030 |
Why?
| | Resuscitation | 1 | 2020 | 302 | 0.030 |
Why?
| | Exons | 1 | 2018 | 358 | 0.030 |
Why?
| | Seizures | 1 | 2020 | 460 | 0.030 |
Why?
| | Niacinamide | 1 | 1997 | 86 | 0.030 |
Why?
| | Protein Isoforms | 1 | 2018 | 402 | 0.030 |
Why?
| | Nerve Fibers, Myelinated | 1 | 2016 | 47 | 0.030 |
Why?
| | Protein Transport | 1 | 2018 | 441 | 0.030 |
Why?
| | Mice, Inbred ICR | 1 | 2016 | 113 | 0.030 |
Why?
| | Glutathione Transferase | 1 | 2016 | 100 | 0.030 |
Why?
| | Glucose Transporter Type 1 | 1 | 2016 | 48 | 0.030 |
Why?
| | Inpatients | 1 | 2021 | 542 | 0.030 |
Why?
| | Protein Domains | 1 | 2018 | 313 | 0.030 |
Why?
| | Cell Polarity | 1 | 1997 | 137 | 0.030 |
Why?
| | Biological Transport | 1 | 2017 | 412 | 0.030 |
Why?
| | Heme Oxygenase-1 | 1 | 2016 | 74 | 0.030 |
Why?
| | Cytokines | 2 | 2014 | 2061 | 0.030 |
Why?
| | Stromal Cells | 1 | 2016 | 124 | 0.030 |
Why?
| | Hypoxia | 2 | 2014 | 1199 | 0.030 |
Why?
| | Cysteine | 1 | 1997 | 210 | 0.030 |
Why?
| | Pharmaceutical Preparations | 1 | 2017 | 169 | 0.030 |
Why?
| | Functional Laterality | 1 | 2016 | 241 | 0.030 |
Why?
| | Adult | 2 | 2021 | 40262 | 0.030 |
Why?
| | Estrogen Receptor alpha | 2 | 2010 | 161 | 0.030 |
Why?
| | Adolescent | 3 | 2021 | 22281 | 0.030 |
Why?
| | Receptors, Estrogen | 2 | 2012 | 457 | 0.030 |
Why?
| | Endothelial Cells | 1 | 2021 | 869 | 0.030 |
Why?
| | Adenosine Triphosphate | 1 | 1997 | 498 | 0.030 |
Why?
| | Neurologic Examination | 1 | 2015 | 130 | 0.030 |
Why?
| | Blood Vessels | 1 | 2016 | 171 | 0.030 |
Why?
| | T-Lymphocytes | 2 | 2015 | 1982 | 0.030 |
Why?
| | Hindlimb | 1 | 2015 | 131 | 0.030 |
Why?
| | California | 1 | 2016 | 469 | 0.030 |
Why?
| | Colorado | 1 | 2025 | 4562 | 0.030 |
Why?
| | Chronic Disease | 1 | 2021 | 1812 | 0.030 |
Why?
| | Nanostructures | 1 | 2016 | 117 | 0.030 |
Why?
| | Locomotion | 1 | 2015 | 105 | 0.030 |
Why?
| | Reactive Oxygen Species | 1 | 1997 | 621 | 0.030 |
Why?
| | Drug Evaluation, Preclinical | 1 | 2014 | 194 | 0.030 |
Why?
| | Hematoxylin | 1 | 2013 | 8 | 0.030 |
Why?
| | Eosine Yellowish-(YS) | 1 | 2013 | 10 | 0.030 |
Why?
| | Fluoresceins | 1 | 2013 | 48 | 0.030 |
Why?
| | Constriction | 1 | 2013 | 47 | 0.030 |
Why?
| | Arginine | 1 | 2015 | 262 | 0.030 |
Why?
| | Gene Expression Regulation | 1 | 2003 | 2603 | 0.030 |
Why?
| | Chalcones | 1 | 2013 | 7 | 0.030 |
Why?
| | CREB-Binding Protein | 1 | 2013 | 34 | 0.030 |
Why?
| | Movement | 1 | 2016 | 293 | 0.020 |
Why?
| | Cohort Studies | 1 | 2024 | 5935 | 0.020 |
Why?
| | Odds Ratio | 1 | 2016 | 1072 | 0.020 |
Why?
| | Protein Binding | 1 | 2020 | 2270 | 0.020 |
Why?
| | Ligation | 1 | 2013 | 92 | 0.020 |
Why?
| | Apamin | 2 | 2004 | 4 | 0.020 |
Why?
| | Mice, Inbred C3H | 1 | 2013 | 251 | 0.020 |
Why?
| | Multivariate Analysis | 1 | 2016 | 1533 | 0.020 |
Why?
| | Fluorescein-5-isothiocyanate | 1 | 2012 | 36 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2013 | 240 | 0.020 |
Why?
| | Hypoglycemic Agents | 2 | 1999 | 1379 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2017 | 2111 | 0.020 |
Why?
| | Fibronectins | 1 | 2012 | 136 | 0.020 |
Why?
| | Kidney Glomerulus | 1 | 2012 | 128 | 0.020 |
Why?
| | Proteins | 1 | 1997 | 1021 | 0.020 |
Why?
| | Lymphocyte Subsets | 1 | 2011 | 83 | 0.020 |
Why?
| | Receptors, CCR7 | 1 | 2011 | 31 | 0.020 |
Why?
| | Comorbidity | 1 | 2016 | 1646 | 0.020 |
Why?
| | Receptors, CCR5 | 1 | 2011 | 60 | 0.020 |
Why?
| | Logistic Models | 1 | 2016 | 2104 | 0.020 |
Why?
| | Hyaluronan Receptors | 1 | 2011 | 102 | 0.020 |
Why?
| | Mice, SCID | 1 | 2011 | 369 | 0.020 |
Why?
| | Blood | 1 | 2011 | 109 | 0.020 |
Why?
| | Enzyme Induction | 1 | 2010 | 88 | 0.020 |
Why?
| | Transplantation, Homologous | 1 | 2011 | 415 | 0.020 |
Why?
| | Statistics, Nonparametric | 1 | 2011 | 427 | 0.020 |
Why?
| | Fluorescent Dyes | 1 | 2012 | 329 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2018 | 2494 | 0.020 |
Why?
| | Aromatase | 1 | 2010 | 32 | 0.020 |
Why?
| | Kidney Cortex | 1 | 2010 | 27 | 0.020 |
Why?
| | Blood Urea Nitrogen | 1 | 2010 | 53 | 0.020 |
Why?
| | Acute-Phase Proteins | 1 | 2010 | 67 | 0.020 |
Why?
| | Lipocalins | 1 | 2010 | 35 | 0.020 |
Why?
| | Exploratory Behavior | 1 | 2010 | 86 | 0.020 |
Why?
| | Estrogen Receptor beta | 1 | 2010 | 43 | 0.020 |
Why?
| | Aromatase Inhibitors | 1 | 2010 | 75 | 0.020 |
Why?
| | Lipopolysaccharides | 1 | 2013 | 863 | 0.020 |
Why?
| | Oncogene Proteins | 1 | 2010 | 61 | 0.020 |
Why?
| | Renal Circulation | 1 | 2010 | 75 | 0.020 |
Why?
| | Anti-Inflammatory Agents | 1 | 2013 | 474 | 0.020 |
Why?
| | Lipocalin-2 | 1 | 2010 | 79 | 0.020 |
Why?
| | Castration | 1 | 2009 | 15 | 0.020 |
Why?
| | Blood Chemical Analysis | 1 | 2010 | 108 | 0.020 |
Why?
| | Androgen Receptor Antagonists | 1 | 2009 | 35 | 0.020 |
Why?
| | Histone Deacetylase Inhibitors | 1 | 2010 | 220 | 0.020 |
Why?
| | Androgen Antagonists | 1 | 2009 | 91 | 0.020 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2013 | 1217 | 0.020 |
Why?
| | Creatinine | 1 | 2010 | 505 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2017 | 5389 | 0.020 |
Why?
| | Wound Healing | 1 | 2010 | 351 | 0.020 |
Why?
| | Flow Cytometry | 1 | 2011 | 1172 | 0.020 |
Why?
| | Evidence-Based Medicine | 1 | 2010 | 729 | 0.010 |
Why?
| | Autoimmunity | 1 | 2011 | 924 | 0.010 |
Why?
| | Pediatrics | 1 | 2013 | 1112 | 0.010 |
Why?
| | Infant | 1 | 2018 | 10022 | 0.010 |
Why?
| | Young Adult | 1 | 2021 | 13990 | 0.010 |
Why?
| | In Situ Hybridization | 1 | 2004 | 319 | 0.010 |
Why?
| | Child, Preschool | 1 | 2018 | 11774 | 0.010 |
Why?
| | Evoked Potentials | 1 | 2004 | 128 | 0.010 |
Why?
| | Blood Pressure | 1 | 2010 | 1759 | 0.010 |
Why?
| | COS Cells | 1 | 2003 | 181 | 0.010 |
Why?
| | Intracellular Membranes | 1 | 2003 | 76 | 0.010 |
Why?
| | Myoblasts | 1 | 2003 | 84 | 0.010 |
Why?
| | Genes, Reporter | 1 | 2003 | 275 | 0.010 |
Why?
| | Egtazic Acid | 1 | 2001 | 38 | 0.010 |
Why?
| | Sarcoplasmic Reticulum | 1 | 2001 | 42 | 0.010 |
Why?
| | Enhancer Elements, Genetic | 1 | 2003 | 192 | 0.010 |
Why?
| | Cobalt | 1 | 2001 | 53 | 0.010 |
Why?
| | Chelating Agents | 1 | 2001 | 70 | 0.010 |
Why?
| | Potassium | 1 | 2001 | 152 | 0.010 |
Why?
| | Calcium Channels | 1 | 2001 | 154 | 0.010 |
Why?
| | Electromyography | 1 | 2002 | 415 | 0.010 |
Why?
| | Muscle Contraction | 1 | 2002 | 428 | 0.010 |
Why?
| | Base Sequence | 1 | 2003 | 2187 | 0.010 |
Why?
| | Molecular Sequence Data | 1 | 2003 | 2929 | 0.010 |
Why?
| | Biotransformation | 1 | 1997 | 62 | 0.010 |
Why?
| | Transcription, Genetic | 1 | 2003 | 1495 | 0.010 |
Why?
| | Leptin | 1 | 1997 | 244 | 0.010 |
Why?
| | Xenopus laevis | 1 | 1996 | 105 | 0.010 |
Why?
| | Potassium Channel Blockers | 1 | 1996 | 47 | 0.010 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 1996 | 330 | 0.010 |
Why?
| | Macromolecular Substances | 1 | 1996 | 224 | 0.010 |
Why?
| | Oocytes | 1 | 1996 | 178 | 0.010 |
Why?
| | DNA Primers | 1 | 1996 | 511 | 0.010 |
Why?
|
|
Herson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|